Weight gain during the dolutegravir transition in the African Cohort Study.
Allahna L EsberDavid ChangMichael IroezinduEmmanuel BahemanaHannah KibuukaJohn OwuothValentine SingoeiJonah MaswaiNicole F DearTrevor A CrowellChristina S PolyakJulie A Akenull nullPublished in: Journal of the International AIDS Society (2022)
Elevated BMI and weight gain among PLWH on TLD are concerning safety signals. Implications for the development of metabolic comorbidities should be monitored, particularly if annual weight gain persists during continued follow-up after transitioning to TLD.